Skip to content
Agentic 10-K

HealthLynked CorpHLYK

AI agent disclosures in SEC filings, deployment confirmed

As of 2026-07-16, HealthLynked Corp (HLYK) disclosed AI-agent language in 5 SEC filings since 2026-02-10, including 1 excerpt describing its own deployment of AI agents (source: Agentic 10-K, from SEC EDGAR).

Market cap
$6MYahoo Finance, 2026-10-21
First seen
2026-02-10
Latest filing
2026-07-16

Matching filings by quarter

012Q1 '25Q2Q3Q42Q1 '262Q21Q3Q4*
Filings* Quarter in progress

What the filings cover

Functions named

Healthcare & clinical, Operations & supply chain, Sales & marketing

Vendors and products named

Referrizer

Source

5 filings since 2025-01-01. All EDGAR filings (opens in a new tab)

Stage and function are keyword-rule labels, not the company’s words.

In its own words

Sentences copied from the filings, whitespace normalised.

“AI Agent for Patient Engagement and Appointment Booking – We have filed a provisional patent application covering AI-enabled agent technology designed to automate and assist with patient engagement activities, including outbound and inbound communications, appointment scheduling, care coordination tasks, and related workflow automation.”

S-1Filed 2026-02-10Confirmed deploymentSource on sec.gov (opens in a new tab)Filing index (opens in a new tab)

“O’Leary is Vice Chairman of Referrizer, LLC, a private marketing automation company, currently offering AI agents to its clients, since January 2016.”

8-KFiled 2026-07-16Source on sec.gov (opens in a new tab)Filing index (opens in a new tab)

All matching filings

8-K filed 2026-07-16 Filing index (opens in a new tab)

8-KFiled 2026-07-16

Mr. O'Leary is Vice Chairman of Referrizer, which offers AI agents to clients.

“Mr. O’Leary is a financially trained senior executive specializing in innovative strategic problem solving across functional and industry boundaries. Most recently, Mr. O’Leary was CEO of Sono Group NV (Nasdaq: SSM) from April 2024 through December 2025, where he took the company from the OTCQB and uplisted to the Nasdaq Capital Market in September 2025 and as fractional CFO for New America Acquisition I Corp. (NYSE: NWAX-UN) participated in the SPAC IPO on the NYSE in December 2025. Mr. O’Leary is Vice Chairman of Referrizer, LLC, a private marketing automation company, currently offering AI agents to its clients, since January 2016. Mr. O’Leary was the Vice-Chairman of the board of directors of Timios Holdings Corp. from March 2014 through January 2021. From June 2009 to May 2013 Mr. O’Leary was Chairman of the Board and Chief Financial Officer of Protection Plus Securities Corporation until it was sold to Universal Protection Services. From February 2007 to June 2015, Mr. O’Leary was a member of the Board of Directors of NeoMedia Technologies. Mr. O’Leary is founder and President of SKS Consulting of South Florida Corp. (“SKS”) since June 2006 where he works with public and private companies in board representation and/or under consulting agreements providing executive level management expertise, as well as helping the implementation and execution of their companies’ strategic & operational plans.”

S-1 filed 2026-05-29 Filing index (opens in a new tab)

S-1, S-1/AFiled 2026-05-29

HealthLynked filed provisional patent for AI agent for patient engagement and booking.

“AI Agent for Patient Engagement and Appointment Booking – We have filed a provisional patent application covering AI-enabled agent technology designed to automate and assist with patient engagement activities, including outbound and inbound communications, appointment scheduling, care coordination tasks, and related workflow automation.”

S-1 filed 2026-04-30 Filing index (opens in a new tab)

S-1, S-1/AFiled 2026-04-30

HealthLynked filed a provisional patent for AI agent technology to automate patient engagement and appointment scheduling.

“AI Agent for Patient Engagement and Appointment Booking – We have filed a provisional patent application covering AI-enabled agent technology designed to automate and assist with patient engagement activities, including outbound and inbound communications, appointment scheduling, care coordination tasks, and related workflow automation.”

10-K filed 2026-03-31 Filing index (opens in a new tab)

10-KFiled 2026-03-31

Filed provisional patent for AI-enabled agent technology to automate patient engagement and appointment booking.

“AI Agent for Patient Engagement and Appointment Booking – We have filed a provisional patent application covering AI-enabled agent technology designed to automate and assist with patient engagement activities, including outbound and inbound communications, appointment scheduling, care coordination tasks, and related workflow automation.”

S-1 filed 2026-02-10 Filing index (opens in a new tab)

S-1Filed 2026-02-10

HealthLynked filed a provisional patent for an AI agent that automates patient engagement and appointment booking.

“AI Agent for Patient Engagement and Appointment Booking – We have filed a provisional patent application covering AI-enabled agent technology designed to automate and assist with patient engagement activities, including outbound and inbound communications, appointment scheduling, care coordination tasks, and related workflow automation.”